Science is a fluctuating, complex and even time-consuming endeavor and this is why not many can engage in it. It is also important to make a distinction here between science and scientism. Science is intellectual rigor and requires intense critical work, while scientism is what you read in magazines, and can be said to be science just for science’s sake. Real science is what people should concentrate on. Fortunately, real science is the focus today of Brazilian neuroscientist Jorge Moll.
One of the most famous articles that Jorge Moll helped publish is the article at Science Daily involving the results of a neuroimaging of soccer fans. The study done through the experts and researchers from D’Or Institute for Research and Education revealed impressive results.
The study answered, among many questions, the inquiry about why soccer fans feel strongly for the teams they support. It also answers why people feel good when they take part in activities that involve the groups that they belong to. Published also in Nature’s Scientific Reports, Jorge Moll’s work has shown that all of these feelings of affinity for a team or group is ingrained in our brains. It is revealed that it is already part of our humanity to be part of a group. This is because such participation increases our chances of survival, gives us pleasure, and gives us more chances of favorable consequences in natural selection.
About Jorge Moll
Jorge Moll is most known for his intelligence, dedication and passion for being the President of D’Or Institute for Research and Education (IDOR), which is based in Rio de Janeiro, Brazil. He is also the Senior Researcher in IDOR’s Cognitive Neuroscience Unit and Neuroinformatics Workgroup. His distinctions include being the Affiliate Member of the Brazilian Academy of Sciences.
Moll got his Neurology degree at the Universidade Federal do Rio de Janeiro, and his PhD in Experimental Physiopathology at the Escola Superior de Agricultura Luiz de Queiroz da Universidade de São Paulo. His expertise in research has clearly grown into a body of work that’s been respected by fellow researchers studying human behaviour and emotional cognition.
Jeff Aronin serves as the Chief Executive Officer and chairman of the Paragon Biosciences. With a wide experience and the deep knowledge that Jeff Aronin Possesses, it makes him one of the leading entrepreneurs in healthcare and biotechnology. By manipulation of his entrepreneurial energy and his expertise in his industry, he is working towards the foundation of a top investor and incubator of young startups biotech companies.
While still young in his career, Jeff Aronin knew that his passion was totally in the sector of health care. One day he got a chance to experience and witness a doctor treat a baby with constant seizure, and this resulted to making a deep impact on Aronin’s career decision. This was because instead of the doctor administering a major brain surgery on the child, he used medicine as an option, which made Aronin comprehend the power of medicine and pharmaceuticals.
Back in the year 2000, Jeff Aronin founded and became the Chief Executive Officer of Ovation Pharmaceutical Inc. At the Ovation Pharmaceutical the strategy mainly entailed comprehension of the needs of the patients, finding promising science and finally bringing a team together for the approving of the medicine. After Ovation Pharmaceutical Inc. had been operational for about nine years, it was bought by Lundbeck at 900 million dollars. After it was purchased, Jeff Aronin still served as the president and the Chief Executive Officer so as to oversee the new transition.
At paragon Biosciences, Jeff Aronin has been the CEO for the last ten years. His specialization in patient drug development and also in complex science has resulted to him becoming one of the most innovative and successful leaders in the field of bioscience. What Jeff basically does is try to address the requirements of patients with rare disorders, which are unmet.
Jeff Aronin being a scientific visionary person and an entrepreneur have largely attributed to the approval of more than 12 new technologies and medicines. Apart from the posts mentioned above, where he served in leadership positions, Jeff Aronin was also once a chairman in a number of several life companies such as Castle Creek Pharmaceuticals, Harmony Biosciences and the Paragon Pharmaceuticals.